Summit Technology
This article was originally published in The Gray Sheet
Executive Summary
Acquires EyeTech Vision A.G.' s Krumeich-Barraquer microkeratome, an instrument used to create the corneal flap in laser in situ keratomileusis procedures, Summit says Oct. 29. The company will assume international sales responsibilities immediately; release in the U.S. is expected following FDA clearance of a pending 510(k). Twenty-five of the devices, which sell for between $55,000-$60,000 each, have been sold in fourteen countries outside the U.S., Summit notes. The system is the only microkeratome device "that has critical surgical parameters controlled by a computer system," Summit claims